Clinical Trial Update: A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated whether the pharmacokinetic disposition of inhaled insulin differs between asthmatics and non-asthmatics; the trial status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Diabetes Mellitus

Drugs mentioned

• Afrezza (Technosphere insulin)

Snippet

Sponsor: Mannkind Corporation | Conditions: Asthma, Diabetes Mellitus | Phase 1 | Status: COMPLETED